Page last updated: 2024-10-26

3,3'-diindolylmethane and Leukemia

3,3'-diindolylmethane has been researched along with Leukemia in 1 studies

3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, N1
Cheng, S1
Budhraja, A1
Liu, EH1
Chen, J1
Chen, D1
Yang, Z1
Luo, J1
Shi, X1
Zhang, Z1

Other Studies

1 other study available for 3,3'-diindolylmethane and Leukemia

ArticleYear
3,3'-Diindolylmethane exhibits antileukemic activity in vitro and in vivo through a Akt-dependent process.
    PloS one, 2012, Volume: 7, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Chromones; Cyclin-Dependent K

2012